Poland approves Aurora Cannabis as medical marijuana supplier

Alberta-based Aurora Cannabis said it received the green light to ship medical cannabis to Poland, making the Canadian company “the first nongovernment-run business” to win approval to supply medical marijuana products in the eastern European country.

Aurora Deutschland GmbH – Aurora’s German subsidiary – will ship the products to a pain treatment center and a hospital in Warsaw in the coming days, the company announced in a news release.

Since legalizing medical cannabis in 2017, the Polish medical cannabis market has suffered from a lack of supply. That’s because the supporting legislation bans cultivation within Poland.

Under the legislation, physicians are able to prescribe medical cannabis products to patients, who can then access it through pharmacies.

In some instances, products can be covered under Poland’s statutory health insurance.

Treatable conditions include chemotherapy-induced nausea, multiple sclerosis, chronic pain and epilepsy.

In a regulatory filing in September, Aurora said it is the European Union’s largest distributor of medical cannabis.

Aurora, which employs more than 70 people in Europe, recently established a pan-European company, Aurora Europe GmbH, headquartered in Berlin. Other subsidiaries in the European Union include Aurora Italia, Aurora Malta and Aurora Nordic (Denmark).

Aurora did not immediately respond to queries from Marijuana Business Daily.

Aurora’s shares are traded on the New York Stock Exchange as ACB and on the Toronto Stock Exchange as ACB.

To sign up for our weekly international marijuana business newsletter, click here.

Leave a Reply

Your email address will not be published. Required fields are marked *